journal article·2022-07Open access

Regulation of Nucleotide Metabolism with Nutrient‐Sensing Nanodrugs for Cancer Therapy

Xinye Wang, Wen Su, Yongbin Jiang, Fuhao Jia, Wenping Huang, Jie Zhang, Yue Yin, Hai Wang

Advanced Science· Volume 9· Issue 20

Abstract

Abstract The continual growth of tumor cells requires considerable nutrient consumption. Methotrexate (MTX) is used to treat certain types of cancer by blocking the DNA and RNA productions through interfering one‐carbon metabolism and de novo purine and pyrimidine synthesis. However, treatment of MTX may cause many serious adverse effects, which hamper its clinical application. Herein, the authors synthesize ferrous ions, histidine, and MTX assembled nanoparticles (FHM) to deliver MTX at tumor site and enhance the sensitivity of tumor cells to MTX with histidine catabolism. Furthermore, fasting‐mimicking diet (FMD) is applied to intervene in the one‐carbon metabolism and enhance the cytotoxicity of MTX. Meanwhile, FMD treatment can significantly augment the cellular uptake and tumor accumulation of FHM nanoparticles. Due to the triple inhibitions of the one‐carbon metabolism, the proliferation of tumor cells is strongly disturbed, as which is highly replying on DNA and RNA production. Taken together, a 95% lower dose of MTX adopted in combined therapy significantly inhibits the growth of two types of murine tumors without evident systemic toxicity. This strategy may provide a promising nucleotide metabolism‐based nanomedicine for cancer therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Epigenetics and DNA Methylation · Cancer, Hypoxia, and Metabolism · MicroRNA in disease regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety CAS Center for Excellence in Nanoscience National Center for Nanoscience and Technology Beijing 100190 China

University of Chinese Academy of Sciences Beijing 100049 China

Zhangjiakou First Hospital Zhangjiakou 075000 China

Funding

National Natural Science Foundation of China

References (47)

Show source-provided references
1. 10.1016/j.cmet.2015.12.00610.1016/j.cmet.2015.12.006 ↗
2. 10.1038/nrd350410.1038/nrd3504 ↗
3. 10.1038/s41586-018-0316-710.1038/s41586-018-0316-7 ↗
4. 10.1002/advs.20210518810.1002/advs.202105188 ↗
5. 10.1016/j.bbrc.2016.12.09810.1016/j.bbrc.2016.12.098 ↗
6. 10.1038/nrc355710.1038/nrc3557 ↗
7. 10.1038/s41467-020-20223-y10.1038/s41467-020-20223-y ↗
8. 10.1038/s41420-021-00474-410.1038/s41420-021-00474-4 ↗
9. 10.1038/nature1154010.1038/nature11540 ↗
10. 10.1073/pnas.120417610910.1073/pnas.1204176109 ↗
11. 10.1038/nrc.2016.8110.1038/nrc.2016.81 ↗
12. 10.1016/j.celrep.2014.04.04510.1016/j.celrep.2014.04.045 ↗
13. 10.1126/science.aau209510.1126/science.aau2095 ↗
14. 10.1038/s41586-020-2124-010.1038/s41586-020-2124-0 ↗
15. 10.1002/pmic.20140005110.1002/pmic.201400051 ↗
16. 10.1038/s41586-020-2502-710.1038/s41586-020-2502-7 ↗
17. 10.1016/j.cmet.2015.05.01210.1016/j.cmet.2015.05.012 ↗
18. 10.1186/s12885-016-2370-610.1186/s12885-016-2370-6 ↗
19. 10.1186/s12885-018-4353-210.1186/s12885-018-4353-2 ↗
20. 10.18632/aging.10011410.18632/aging.100114 ↗
21. 10.1186/s12885-015-1663-510.1186/s12885-015-1663-5 ↗
22. 10.1126/scitranslmed.300329310.1126/scitranslmed.3003293 ↗
23. 10.1126/science.117253910.1126/science.1172539 ↗
24. 10.1093/advances/nmz07910.1093/advances/nmz079 ↗
25. 10.1038/s41467-020-20588-010.1038/s41467-020-20588-0 ↗
26. 10.1002/advs.20190324310.1002/advs.201903243 ↗
27. 10.1039/D0CC05520D10.1039/D0CC05520D ↗
28. 10.1039/C9NR05744G10.1039/C9NR05744G ↗
29. 10.1039/D0CY01241F10.1039/D0CY01241F ↗
30. 10.1039/C9DT04755G10.1039/C9DT04755G ↗
31. 10.1039/C7TA03304D10.1039/C7TA03304D ↗
32. 10.1039/D0TA02770G10.1039/D0TA02770G ↗
33. 10.1002/anie.20171266210.1002/anie.201712662 ↗
34. 10.1016/j.jallcom.2021.16167810.1016/j.jallcom.2021.161678 ↗
35. 10.1039/C7RA06205B10.1039/C7RA06205B ↗
36. 10.1016/j.desal.2020.11452210.1016/j.desal.2020.114522 ↗
37. 10.1039/D1DT02595C10.1039/D1DT02595C ↗
38. 10.1039/D0NR03987J10.1039/D0NR03987J ↗
39. 10.1021/acs.nanolett.2c0035610.1021/acs.nanolett.2c00356 ↗
40. 10.1016/j.nut.2012.02.01410.1016/j.nut.2012.02.014 ↗
41. 10.18632/oncotarget.368810.18632/oncotarget.3688 ↗
42. 10.1146/annurev.genet.41.110306.13030810.1146/annurev.genet.41.110306.130308 ↗
43. 10.1038/258173a010.1038/258173a0 ↗
44. 10.1038/sj.emboj.760032710.1038/sj.emboj.7600327 ↗
45. 10.1093/jn/nxaa07910.1093/jn/nxaa079 ↗
46. 10.1021/acs.nanolett.0c0503910.1021/acs.nanolett.0c05039 ↗
47. 10.1007/s00216-017-0514-410.1007/s00216-017-0514-4 ↗